Episodic Pivots Headlines

Headlines
ASHW | Catalyst: Analyst Upgrade -> Ashworth upgraded by B. Riley & Co
Float: 12 (mil) Institutional Ownership: 62% Relative Strength: 10
IBD EPS Rtg: 8 Net Profit Margin: -4% ROE: -8%
EPS Growth: 225% (1yr) -51% (3yr)
Sales Growth: 2% (1yr) 12% (3yr)

ASYS | Catalyst: New Contract -> Amtech gets $4.9 mln solar order, shares rise
Float: 6 (mil) Institutional Ownership: 23% Relative Strength: 95
IBD EPS Rtg: 13 Net Profit Margin: 0% ROE: %
EPS Growth: 387% (1yr) 0% (3yr)
Sales Growth: 45% (1yr) 28% (3yr)

DIOD | Catalyst: New Product -> Diodes, Inc. Announces Breakthrough 300V SBR(R) Rectifiers with Industry Leading Performance
Float: 20 (mil) Institutional Ownership: 86% Relative Strength: 64
IBD EPS Rtg: 96 Net Profit Margin: 15% ROE: 19%
EPS Growth: 35% (1yr) 55% (3yr)
Sales Growth: 60% (1yr) 36% (3yr)

FSLR | Catalyst: Common Offering -> Continuation - First Solar To Raise $1 Billion In Secondary Offering
Float: 67 (mil) Institutional Ownership: 35% Relative Strength: 99
IBD EPS Rtg: 75 Net Profit Margin: 8% ROE: 2%
EPS Growth: 172% (1yr) 0% (3yr)
Sales Growth: 181% (1yr) 248% (3yr)

FWLT | Catalyst: Cramer -> Sez many of the infrastructure stocks have had a nice pullback lately
Float: 70 (mil) Institutional Ownership: 81% Relative Strength: 99
IBD EPS Rtg: 75 Net Profit Margin: 9% ROE: 0%
EPS Growth: 257% (1yr) 0% (3yr)
Sales Growth: 59% (1yr) -2% (3yr)

GHM | Catalyst: Earnings Report -> Sales jump 37% at Graham
Float: 4 (mil) Institutional Ownership: 36% Relative Strength: 98
IBD EPS Rtg: 59 Net Profit Margin: 9% ROE: 20%
EPS Growth: 52% (1yr) 0% (3yr)
Sales Growth: 19% (1yr) 21% (3yr)

GPCB | Catalyst: Biotech/Drug Approval -> GPC Biotech's stock rebounded Monday after the company withdrew its new-drug application (NDA) for accelerated approval of prostate cancer drug satraplatin.
Float: 32 (mil) Institutional Ownership: 30% Relative Strength: 1
IBD EPS Rtg: 12 Net Profit Margin: -333% ROE: -73%
EPS Growth: 6% (1yr) 0% (3yr)
Sales Growth: 143% (1yr) 2% (3yr)

GRMN | Catalyst: Takeover, merger etc -> Garmin shares surged $5.17, or 6.5 percent, to $85.07. A CIBC World Markets Corp. analyst said the handheld satellite-based navigation device maker could make a bid for Navteq Corp., which develops digital maps.
Float: 100 (mil) Institutional Ownership: 31% Relative Strength: 95
IBD EPS Rtg: 98 Net Profit Margin: 29% ROE: 38%
EPS Growth: 65% (1yr) 42% (3yr)
Sales Growth: 73% (1yr) 46% (3yr)

INAP | Catalyst: Barron's. WSJ, BW etc story -> Tiny Rival Takes Aim at Akamai
Float: 40 (mil) Institutional Ownership: 53% Relative Strength: 23
IBD EPS Rtg: 45 Net Profit Margin: -4% ROE: -3%
EPS Growth: 170% (1yr) 0% (3yr)
Sales Growth: 18% (1yr) 9% (3yr)

ISRG | Catalyst: Earnings Report -> Continuation
Float: 36 (mil) Institutional Ownership: 95% Relative Strength: 98
IBD EPS Rtg: 98 Net Profit Margin: 21% ROE: 16%
EPS Growth: -25% (1yr) 0% (3yr)
Sales Growth: 64% (1yr) 60% (3yr)

MA | Catalyst: Earnings Report -> Anticipation for 8/1 Earnings report?
Float: 37 (mil) Institutional Ownership: 78% Relative Strength: 98
IBD EPS Rtg: 74 Net Profit Margin: 4% ROE: 7%
EPS Growth: -81% (1yr) 0% (3yr)
Sales Growth: 13% (1yr) 14% (3yr)

MCX | Catalyst: Takeover, merger etc -> MC Shipping to be bought by Bear Stearns Merchant for $284 mln
Float: 4 (mil) Institutional Ownership: 14% Relative Strength: 78
IBD EPS Rtg: 66 Net Profit Margin: 16% ROE: 19%
EPS Growth: -7% (1yr) 47% (3yr)
Sales Growth: 48% (1yr) 14% (3yr)

MSA | Catalyst: Analyst Upgrade -> Mine Safety upgraded by Robert W. Baird
Float: 29 (mil) Institutional Ownership: 73% Relative Strength: 58
IBD EPS Rtg: 47 Net Profit Margin: 7% ROE: 15%
EPS Growth: -21% (1yr) 10% (3yr)
Sales Growth: 1% (1yr) 10% (3yr)

PCCC | Catalyst: Earnings Report -> PC Connection Q2 earnings rise
Float: 9 (mil) Institutional Ownership: 47% Relative Strength: 76
IBD EPS Rtg: 92 Net Profit Margin: 1% ROE: 8%
EPS Growth: 204% (1yr) 32% (3yr)
Sales Growth: 13% (1yr) 8% (3yr)

RCCC | Catalyst: Takeover, merger etc -> Verizon to buy Rural Cellular in $2.67B deal
Float: 13 (mil) Institutional Ownership: 51% Relative Strength: 99
IBD EPS Rtg: 18 Net Profit Margin: -18% ROE: 0%
EPS Growth: -65% (1yr) 0% (3yr)
Sales Growth: 4% (1yr) 4% (3yr)

SPW | Catalyst: New Contract -> SPX lands Chinese nuclear contract, SPX Corp upgraded by Citigroup
Float: 56 (mil) Institutional Ownership: 83% Relative Strength: 92
IBD EPS Rtg: 39 Net Profit Margin: 4% ROE: 11%
EPS Growth: 21861% (1yr) 29% (3yr)
Sales Growth: 12% (1yr) 7% (3yr)

TEX | Catalyst: Earnings Report -> Terex Raises Its Full-Year Guidance 2Q Profit Climbs on Higher Sales
Float: 101 (mil) Institutional Ownership: 81% Relative Strength: 93
IBD EPS Rtg: 99 Net Profit Margin: 6% ROE: 28%
EPS Growth: 110% (1yr) 0% (3yr)
Sales Growth: 24% (1yr) 25% (3yr)

UBH | Catalyst: Takeover, merger etc -> Continuation
Float: 16 (mil) Institutional Ownership: 17% Relative Strength: 72
IBD EPS Rtg: 36 Net Profit Margin: 30% ROE: 14%
EPS Growth: -6% (1yr) 2% (3yr)
Sales Growth: 12% (1yr) 11% (3yr)

VVUS | Catalyst: Biotech/Drug Approval -> Vivus receives FDA approval of Evamist NDA; eligible to receive milestone payment of $140,000,000 from KV Pharmaceutical
Float: 56 (mil) Institutional Ownership: 51% Relative Strength: 90
IBD EPS Rtg: 28 Net Profit Margin: -114% ROE: -60%
EPS Growth: 21% (1yr) 0% (3yr)
Sales Growth: 18% (1yr) -14% (3yr)

WMAR | Catalyst: Earnings Report -> Continuation
Float: 15 (mil) Institutional Ownership: 74% Relative Strength: 51
IBD EPS Rtg: 44 Net Profit Margin: -1% ROE: -2%
EPS Growth: -203% (1yr) 0% (3yr)
Sales Growth: 4% (1yr) 3% (3yr)

WSTG | Catalyst: Earnings Report ->
Float: 4 (mil) Institutional Ownership: 20% Relative Strength: 33
IBD EPS Rtg: 93 Net Profit Margin: 2% ROE: 17%
EPS Growth: 19% (1yr) 43% (3yr)
Sales Growth: 32% (1yr) 38% (3yr)


No headlines
FXI
IAI
ICE
KIE
PZJ
RSP
TMB
XSD